Distinguishing between Rigor and Transparency in FDA Marketing Authorization of AI-enabled Medical Devices

Performance validation rigor and transparency are distinct yet often conflated aspects of U.S. Food and Drug Administration marketing authorization. Authors summarize the current state of each for radiology AI devices and offer recommendations that balance innovation, risk, and public trust.